Overview
Glenn Halff is a Transplant Surgeon and a General Surgeon in San Antonio, Texas. Dr. Halff is rated as an Experienced provider by MediFind in Hepatectomy. His top areas of expertise are Fibrolamellar Carcinoma, Pancreatic Cancer, Liver Cancer, Liver Transplant, and Pancreatectomy. Dr. Halff is currently accepting new patients.
His clinical research consists of co-authoring 26 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
7979 Wurzbach Rd, San Antonio, TX 78229
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Texas Oncology PA
Lokesh Bathla is a Transplant Surgeon and a General Surgeon in San Antonio, Texas. Dr. Bathla is rated as a Distinguished provider by MediFind in Hepatectomy. His top areas of expertise are Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Familial Pancreatic Cancer, Hepatectomy, and Pancreatectomy. Dr. Bathla is currently accepting new patients.
Methodist Physician Practices PLLC
Luke Shen is a Transplant Surgeon and a General Surgeon in San Antonio, Texas. Dr. Shen is rated as a Distinguished provider by MediFind in Hepatectomy. His top areas of expertise are Polycystic Kidney Disease, End-Stage Renal Disease (ESRD), Alcoholic Cirrhosis, Simultaneous Pancreas Kidney Transplant, and Kidney Transplant. Dr. Shen is currently accepting new patients.
Methodist Physician Practices PLLC
Preston Foster is a Transplant Surgeon and a General Surgeon in San Antonio, Texas. Dr. Foster is rated as an Advanced provider by MediFind in Hepatectomy. His top areas of expertise are Liver Failure, Alcoholic Cirrhosis, Hepatitis, Liver Transplant, and Hepatectomy. Dr. Foster is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Fibrolamellar CarcinomaDr. Halff isAdvanced. Learn about Fibrolamellar Carcinoma.
- Liver CancerDr. Halff isAdvanced. Learn about Liver Cancer.
- Liver TransplantDr. Halff isAdvanced. Learn about Liver Transplant.
- Pancreatic CancerDr. Halff isAdvanced. Learn about Pancreatic Cancer.
- Experienced
- Alcoholic CirrhosisDr. Halff isExperienced. Learn about Alcoholic Cirrhosis.
- Ampullary CancerDr. Halff isExperienced. Learn about Ampullary Cancer.
- Bile Duct StrictureDr. Halff isExperienced. Learn about Bile Duct Stricture.
- Cholangiocarcinoma (Bile Duct Cancer)Dr. Halff isExperienced. Learn about Cholangiocarcinoma (Bile Duct Cancer).
- CholecystitisDr. Halff isExperienced. Learn about Cholecystitis.
- Chronic Antibody-Mediated RejectionDr. Halff isExperienced. Learn about Chronic Antibody-Mediated Rejection.